Evidence map›Paper›PMID 28740621›Full record

ArticleJournal of market access & health policy2017

Direct cost analysis of the second year post-allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Centre of Tunisia.

Myriam Razgallah Khrouf, Leila Achour, Asma Thabti, Mohamed Ali Soussi, Nour Abdejelil, Olfa Lazreg, Chema Drira, Aida Zahaf, Saloua Ladab, Tarek Ben Othman

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of market access & health policy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease.The European journal of health economics : HEPAC : health economics in prevention and care · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Myriam Razgallah KhroufService Pharmacie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia.
Leila AchourService Pharmacie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia.
Asma ThabtiService Pharmacie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia.
Mohamed Ali SoussiService Pharmacie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia.
Nour AbdejelilService de Greffe et Hématologie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia.
Olfa LazregService Pharmacie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia.
Chema DriraService Pharmacie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia.
Aida ZahafService Pharmacie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia.
Saloua LadabService de Greffe et Hématologie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia.
Tarek Ben OthmanService de Greffe et Hématologie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia.ORCID 0000-0002-6820-3862
University of Monastir · TNTunis University · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Allogeneic stem cell transplantationcomplicationscostpharmacoeconomic

Identifiers

PMID28740621
PMCPMC5508398
OpenAlexW2626339694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.